The Enterprise Value as of December 2025 (TTM) for Aplus Biotechnology Corporation Limited (6918.TWO) is 2.44B

According to Aplus Biotechnology Corporation Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 2.44B. This represents a change of -2.94% compared to the average of 2.51B of the last 4 quarters.

Aplus Biotechnology Corporation Limited (6918.TWO) Historical Enterprise Value (quarterly & annually)

How has 6918.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of Aplus Biotechnology Corporation Limited over the last ten years is 1.45B. The current 2.44B Enterprise Value has changed 16.70% with respect to the historical average. Over the past ten years (40 quarters), 6918.TWO's Enterprise Value was at its highest in in the March 2025 quarter at 2.99B. The Enterprise Value was at its lowest in in the June 2023 quarter at -127888000.00.

Aplus Biotechnology Corporation Limited (6918.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Aplus Biotechnology Corporation Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aplus Biotechnology Corporation Limited (6918.TWO) Average Enterprise Value

How has 6918.TWO Enterprise Value performed in the past?

The current Enterprise Value of Aplus Biotechnology Corporation Limited (6918.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Aplus Biotechnology Corporation Limited (6918.TWO) Enterprise Value vs. Peers

How is 6918.TWO’s Enterprise Value compared to its peers?

Aplus Biotechnology Corporation Limited’s Enterprise Value is greater than InnoCare Optoelectronics Corporation (1.77B), less than Maywufa Company Ltd. (3.46B), greater than Taiwan Biomaterial Co., Ltd. (1.90B), greater than Dynamic Medical Technologies Inc. (2.31B), less than G&E Herbal Biotechnology Co., Ltd. (2.95B), less than ShareHope Medicine Co., Ltd. (3.63B), greater than Wellell Inc. (1.91B), greater than Johnson Chemical Pharmaceutical Works Co., Ltd. (1.80B), greater than Medical Imaging Corporation (2.24B), less than MedFirst Healthcare Services, Inc. (5.73B),

Build a custom stock screener for Aplus Biotechnology Corporation Limited (6918.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aplus Biotechnology Corporation Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aplus Biotechnology Corporation Limited (6918.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aplus Biotechnology Corporation Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.